Table 4 Treatment in SLE with MS group and SLE without MS group
Treatment | SLE patients without MS (N = 38 patients) | SLE patients with MS (N = 32 patients) | P- value |
|---|---|---|---|
Steroids | 35(92.1%) | 32(%87.5) | 0.695 |
Hydroxychloroquine | 30(%78.9) | 24(%75) | 0.695 |
Cyclophosphamide | 8(%21.1) | 14(%43.8) | 0.042* |
Azathioprine | 12(%31.6) | 8(25%) | 0.445 |
mycophenolate mophetil | 10(%26.3) | 10(%31.3) | 0.649 |
Cyclosporine | 3(%7.9) | 4(12.5%) | 0.695 |